UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

The New England journal of medicine, 2014-08, Vol.371 (7), p.635-645

2014

Volltextzugriff (PDF)

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

Expert review of vaccines, 2018-05, Vol.17 (5), p.435-443

2018

Volltextzugriff (PDF)

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

Vaccine, 2013-01, Vol.31 (5), p.770-776

2013

Volltextzugriff (PDF)

Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults

The New England journal of medicine, 2005-10, Vol.353 (15), p.1555-1563

2005

Volltextzugriff (PDF)

Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine

Vaccine, 2016-10, Vol.34 (44), p.5273-5278

2016

Volltextzugriff (PDF)

Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers

Vaccine, 2016-07, Vol.34 (35), p.4172-4179

2016

Volltextzugriff (PDF)

Bordetella Pertussis Infections in Vaccinated and Unvaccinated Adolescents and Adults, as Assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT)

Clinical infectious diseases, 2006-07, Vol.43 (2), p.151-157

2006

Volltextzugriff (PDF)

Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis

Vaccine, 2021-03, Vol.39, p.A24-A35

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older

Human vaccines & immunotherapeutics, 2017-09, Vol.13 (9), p.2058-2064

2017

Volltextzugriff (PDF)

Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors

Vaccine, 2015-01, Vol.33 (5), p.734-741

2015

Volltextzugriff (PDF)

Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)

Vaccine, 2019-02, Vol.37 (8), p.1016-1020

2019

Volltextzugriff (PDF)

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines

Vaccine, 2015-09, Vol.33 (38), p.4988-4993

2015

Volltextzugriff (PDF)

Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP

Vaccine, 2019-08, Vol.37 (35), p.5003-5008

2019

Volltextzugriff (PDF)

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA

Vaccine, 2018-04, Vol.36 (17), p.2282-2287

2018

Volltextzugriff (PDF)

Immune responses in infants whose mothers received Tdap vaccine during pregnancy

The Pediatric infectious disease journal, 2013-11, Vol.32 (11), p.1257

2013

Volltextzugriff (PDF)

Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media

JAMA : the journal of the American Medical Association, 2006-07, Vol.296 (2), p.202

2006

Volltextzugriff (PDF)

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

The Pediatric infectious disease journal, 2019-03, Vol.38 (3), p.323-328

2019

Volltextzugriff (PDF)

Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty

Vaccine, 2015-08, Vol.33 (36), p.4565-4571

2015

Volltextzugriff (PDF)

Fluzone® High-Dose Influenza Vaccine

Expert review of vaccines, 2016-12, Vol.15 (12), p.1495-1505

2016

Volltextzugriff (PDF)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

The Pediatric infectious disease journal, 2021-12, Vol.40 (12), p.1122-1126

2021

Volltextzugriff (PDF)

Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method

Vaccine, 2019-03, Vol.37 (11), p.1484-1490

2019

Volltextzugriff (PDF)

Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy

The Pediatric infectious disease journal, 2013-11, Vol.32 (11), p.1257-1260

2013

Volltextzugriff (PDF)

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

Vaccine, 2014-05, Vol.32 (21), p.2507-2517

2014

Volltextzugriff (PDF)

Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients

Pediatrics (Evanston), 2005-07, Vol.116 (1), p.160-167

2005

Volltextzugriff (PDF)

Brand-specific rates of pertussis disease among Wisconsin children given 1–4 doses of pertussis Vaccine, 2010–2014

Vaccine, 2020-10, Vol.38 (45), p.7063-7069

2020

Volltextzugriff (PDF)

1 – 25 von 1.039

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(923)
Mit Volltextzugriff
(835)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.037)
Spanisch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults

Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine

Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers

Bordetella Pertussis Infections in Vaccinated and Unvaccinated Adolescents and Adults, as Assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT)

Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older

Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors

Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines

Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA

Immune responses in infants whose mothers received Tdap vaccine during pregnancy

Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty

Fluzone® High-Dose Influenza Vaccine

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method

Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients

Brand-specific rates of pertussis disease among Wisconsin children given 1–4 doses of pertussis Vaccine, 2010–2014

Suchergebnisse filtern